Simcha Therapeutics

Synthekine

This company develops engineered cytokine therapeutics and protein engineering platforms for patients with cancer and autoimmune or inflammatory diseases.

Bright Peak Therapeutics

This biotechnology company develops engineered cytokine immunotherapies and immunoconjugates to treat patients with cancer and autoimmune diseases.

Cold Start Therapeutics

This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.

Siren Bio

This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.

CARGO Therapeutics

This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

ProteoValent Therapeutics

This company develops targeted protein degrader therapies for cancer and haematology patients.

Asher Bio

The company develops cis-targeted immunotherapies that selectively activate specific immune cells to treat patients with cancer and other diseases.